Population Attributable Risk of Hyperuricemia in Hypertension Incidence in 20-74-Year-Old Population during a 10-Year Longitudinal Cohort: Yazd Healthy Heart Cohort
Background: The population attributable risk (PAR) percent has used widely in public health policy. We aimed to calculate the attribute risk of hypertension due to hyperuricemia by Levin's formulas compare to direct PAR calculation method.
Methods: This was a sub-study of Yazd Healthy Heart Cohort (YHHC). Overall, 1256 normotensive individuals were enrolled through multistage randomized cluster sampling and followed up for mean 9.8 years, from 2005-2015. The threshold cutoff point of the hyperuricemia was considered equal and more than 75th percentile that equal to 5.5 mg/dl for men and 4.3mg/dl for women. To calculate the attributable risk of hyperuricemia in developing hypertension, two methods were applied. Levin's formulas and direct PAR estimation by population risk calculation via exposure prevalence weighted formula. Multiple logistic regression was used for estimate of odds ratio (OR) of hyperuricemia in developing hypertension. We calculated Relative Risk (RR) from OR. The data were analyzed using SPSS software version 16. A significant level of 0.05 was considered.
Results: Hypertension developed in 44.7% of individuals with uric acid level ≥ 75th percentile vs. 35.6% of other individuals (P=0.024). Attributable risk (AR) of hyperuricemia in hypertension incidence was 9.1%. PAR of hyperuricemia for hypertension incidence by using two methods mentioned before was 6%, 5.8% respectively.
Conclusion: The results of the study confirmed the noticeable contribution of hyperuricemia as an independent other risk factor for the occurrence of hypertension. PAR of hyperuricemia for hypertension incidence by using two methods almost near was 6%, 5.8% respectively.
Shankarishan, P., et al. (2013). "Population attributable risk estimates for risk factors associated with hypertension in an Indian population." European journal of preventive cardiology 20(6): 963-971
Perlstein, T. S., et al. (2006). "Uric acid and the development of hypertension: the normative aging study." Hypertension 48(6): 1031-1036.
Lee, J.,et al. (2015). "Relationship between uric acid and blood pressure in different age groups." Clinical hypertension 21(1): 14.
Cheng, W., et al. (2017). "The association between serum uric acid and blood pressure in different age groups in a healthy Chinese cohort." Medicine 96(50): e8953.
Laaksonen MA, Knekt P, Härkänen T, Virtala E, Oja H. Estimation of the population attributable fraction for mortality in a cohort study using a piecewise constant hazards model. American journal of epidemiology. 2010 Mar 2;171(7):837-47.
Spiegelman, D., et al. (2007). "Point and interval estimates of partial population attributable risks in cohort studies: examples and software." Cancer Causes & Control 18(5): 571-579.
محمدی and میرزایی (2017). "کسر منتسب به جمعیت بیماریهای قلبی و عروقی در اثر دیابت ملیتوس در شهرستان یزد." ماهنامه علمی پژوهشی دانشگاه علوم پزشکی شهید صدوقی یزد 25(8): 603-611.
درفش بی, et al. (2014). "الگوی فشار خون بالا و سهم منتسب جمعیتی سکته مغزی مرتبط با فشار خون بالا در استان همدان طی سال های 88-1384." مجله تخصصی اپیدمیولوژی ایران 10(3): 54-64.
Stafford, R. J., et al. (2008). "Population-attributable risk estimates for risk factors associated with Campylobacter infection, Australia." Emerging Infectious Diseases 14(6): 895.
Yu, F.-N., et al. (2017). "An observational study on the relationship between serum uric acid and hypertension in a Northern Chinese population aged 45 to 59 years." Medicine 96(17).
Abbas R, Mahdieh NS, Abdoreza R, Hamidreza T, Mahmood SS (2016) Longitudinal Study of Blood Pressure during 8 Years; Patterns and Correlates: Yazd Healthy Heart Project. J Hypertens 5: 215.
Loeffler, L. F., et al. (2012). "Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999–2006." Hypertension 59(4): 811-817.
Forman, J. P., et al. (2009). "Uric acid and insulin sensitivity and risk of incident hypertension." Archives of internal medicine 169(2): 155-162.
|Issue||Vol 49 No 10 (2020)|
|Population attributable risk percentage (PAR%) Hypertension Hyperuricemia Uric acid Iran|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|